Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(25 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama City of Hope, Duarte, California University of California, Los Angeles, Los Angeles, California Stanford University, Stanford, California Moffitt Cancer Center, Tampa, Florida Age range
3 Years – 75 Years
Last updated February 2026